← Leaderboards
Gary D Kao
University Of Pennsylvania
$3,197,441
Attributed
$4,275,376
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $498.8K · FY2005–20$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,275,376 · 4
By mechanism
R01$3,135,620 · 2
RC1$982,256 · 1
R21$157,500 · 1
Top collaborators
- Jay Fitzgerald Dorsey5 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Constantinos Koumenis$17,144,115
- Jerry D Glickson$20,468,757
- Robert H Vonderheide$28,425,019
- Wafik S El-Deiry$15,004,115
- Sydney M Evans$9,029,864
Others in their field
Top investigators on “Anticancer Treatment”
- David Heimbrook · Leidos Biomedical Research, Inc.$240,879,016
- Peter C Adamson · National Childhood Cancer Foundation$124,117,246
- Richard L Schilsky · University Of Chicago$115,275,890
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$107,805,739
- Peter J O'Dwyer · University Of Pennsylvania$85,010,063
- Leonard Freedman · Leidos Biomedical Research, Inc.$75,436,945
Research focus
Anticancer TreatmentRadiationCancer CellBaseMalignant NeoplasmsImaging ModalityRadiation TherapyChemotherapyCharacteristicsTumorGeneticEffectivenessClinical TrialsSiteNeoplastic CellAttentionAdvanced DiseaseComplementAftercareData CollectionDiagnosticBlood SpecimenClinical ManagementBlood
Grant awards (12)
Circulating Tumor Cells Analyses and Molecular Profiling for Patients Receiving Radiation Therapy$433,777
R01 · FY2020 · CA · contact PI
Circulating Tumor Cells Analyses and Molecular Profiling for Patients Receiving Radiation Therapy$420,763
R01 · FY2019 · CA · contact PI
Circulating Tumor Cells Analyses and Molecular Profiling for Patients Receiving Radiation Therapy$433,777
R01 · FY2018 · CA · contact PI
Circulating Tumor Cells Analyses and Molecular Profiling for Patients Receiving Radiation Therapy$433,777
R01 · FY2017 · CA · contact PI
Circulating Tumor Cells Analyses and Molecular Profiling for Patients Receiving Radiation Therapy$433,777
R01 · FY2016 · CA · contact PI
RADIATION-ENHANCED NANOBIOPOLYMER THERAPEUTICS THROUGH THE BLOOD-BRAIN BARRIER$498,770
RC1 · FY2010 · CA · contact PI
RADIATION-ENHANCED NANOBIOPOLYMER THERAPEUTICS THROUGH THE BLOOD-BRAIN BARRIER$483,486
RC1 · FY2009 · CA · contact PI
HDAC4 Viability: Unique Mechanisms and Function$236,702
R01 · FY2007 · CA · contact PI
The Zebrafish Radioresponse for High-Throughput and -Content Molecular Screening$157,500
R21 · FY2007 · NS · contact PI
HDAC4 Viability: Unique Mechanisms and Function$243,771
R01 · FY2006 · CA · contact PI
HDAC4 Viability: Unique Mechanisms and Function$249,638
R01 · FY2005 · CA
HDAC4 Viability: Unique Mechanisms and Function$249,638
R01 · FY2004 · CA